Re: Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam.
Parmar
Malvinder S
MS
Northern Ontario School of Medicine, University of Ottawa, Timmins, Ontario, Canada. atbeat@ntl.sympatico.ca
D000138:Acidosis / Q000139:chemically induced* / Q000378:metabolism; D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000378:metabolism; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D004339:Drug Compounding; D006801:Humans; D008140:Lorazepam / Q000009:adverse effects*; D009994:Osmolar Concentration; D014677:Pharmaceutical Vehicles / Q000009:adverse effects; D019946:Propylene Glycol / Q000009:adverse effects
D014151:Anti-Anxiety Agents; D014677:Pharmaceutical Vehicles; D019946:Propylene Glycol; D008140:Lorazepam